At year one the mean CD4 had dropped and 39 participants (15 in the high and 24 in the low AF-ALB groups) started ART, while at year two the mean CD4 was at its lowest and an additional 33 participants (12 in the high and 21 in the low AF-ALB groups) started ART. This evidence concerns the gene ALB and atrial fibrillation.